The Moran Eye Center was awarded two grants to promote continued research of blindness from Research to Prevent Blindness, a leading voluntary organization in eye research. The center recently received $280,000 in grants to study the causes, treatments and prevention of macular degeneration, a condition that causes vision loss. “We are pleased and honored to [...]
NEW YORK, January 19, 2012 /PRNewswire/ --Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce newly acquiring The Ocular Surface, ...
NEW YORK, Jan. 19, 2012 /PRNewswire/ -- Dr. Gregory S. Hageman, one of the world's most accomplished researchers in the field of Age-Related Macular Degeneration (AMD) will share his discoveries exploring ...
Contact: CONTACT: Andrew Crockett, CEO, KalVista Pharmaceuticals, +44 (0)23 8076 3480 /+44 (0)7872 559676, info@kalvista.com; Chris Gardner / Mark Swallow / Nina Enegren, Citigate Dewe Rogerson (for KalVista), +44 (0)207 638 9571 kalvista@citigatedr.co.uk, Joana Casas, JDRF, +1-212-479-7560, mcasas@jdrf.org
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, today announced treatment of the first patient in its Phase 1/2 clinical trial for Stargardt’s macular dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .
NEW YORK, Jan. 19, 2012 /PRNewswire/ -- Dr. Gregory S. Hageman, one of the world's most accomplished researchers in the field of Age-Related Macular Degeneration (AMD) will share his discoveries exploring the concept that AMD is not a single, complex and progressive disease, but rather at least two diseases manifest by distinctly different biological pathways. He will present his research and ...
|